EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Contraception and Diabetes Mellitus

Theodoros Panou, Evanthia Gouveri, Angeliki Gerede, Panagiotis Tsikouras, Dimitrios Papazoglou, Nikolaos Papanas iD

Experimental and Clinical Endocrinology & Diabetes · 01.05.2025 · 133 (05) · 268-277

DOI: 10.1055/a-2561-9460 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.05.2025. Verfasst von Theodoros Panou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece. Hauptthemen laut MEDLINE: Contraception, Diabetes Mellitus, Diabetes Complications, Hypoglycemic Agents. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this narrative review was to discuss data on contraception in diabetes mellitus (DM). Women with DM rarely discuss contraception with their physicians, and healthcare providers offer advice to a very limited number of them. Overall, 1 in 8 women with DM using contraception methods was found to use an ineffective one. A further issue relates to drug-drug interactions between anti-diabetic medications and oral contraceptives. Generally, anti-diabetic agents do not alter the pharmacologic profile of hormonal contraception. However, preliminary results indicate that some novel anti-diabetic agents may even render oral contraceptive methods ineffective. Several implants can be also generally used by women with both DM types. The relationship between oral contraceptives and diabetic complications has not been clarified yet. In general, implants, intra-uterine devices or progestin-only contraceptives are considered safe options for women with DM. However, short-term use of combined hormonal contraception is also feasible for women without severe complications or risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ContraceptionDiabetes MellitusDiabetes ComplicationsHypoglycemic AgentsHumansFemale

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece.
  • Unit of Maternal-Foetal-Medicine, Department of Obstetrics and Gynaecology, Democritus University of Thrace - Alexandropoulis Campus, Alexandroupolis, Greece.
  • Department of Obstetrics and Gynaecology, Democritus University of Thrace - Alexandropoulis Campus, Alexandroupolis, Greece.

ORCID-Profile: Nikolaos Papanas

Zitieren

APA

Panou, T., Gouveri, E., Gerede, A., Tsikouras, P., Papazoglou, D., & Papanas, N. (2025). Contraception and Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes, 133(05), 268-277. https://doi.org/10.1055/a-2561-9460

Vancouver

Panou T, Gouveri E, Gerede A, Tsikouras P, Papazoglou D, Papanas N. Contraception and Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 2025;133(05):268-277. doi:10.1055/a-2561-9460

BibTeX
@article{Panou2025,
  author = {Panou, Theodoros and Gouveri, Evanthia and Gerede, Angeliki and Tsikouras, Panagiotis and Papazoglou, Dimitrios and Papanas, Nikolaos},
  title = {Contraception and Diabetes Mellitus},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2025},
  volume = {133},
  number = {05},
  pages = {268--277},
  doi = {10.1055/a-2561-9460}
}
Kostenlos starten →